Contribution of increased HMG-CoA reductase gene expression to hypercholesterolemia in experimental chronic renal failure
- 1 April 2003
- journal article
- Published by Springer Nature in Molecular and Cellular Biochemistry
- Vol. 246 (1-2) , 187-191
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Diurnal rhythm of cholesterol biosynthesis in experimental chronic renal failureMolecular and Cellular Biochemistry, 2001
- Lipoprotein abnormalities as a risk factor for progressive nondiabetic renal diseaseKidney International, 1999
- Tissue-specific effect of clofibrate on rat lipogenic enzyme gene expressionEuropean Journal of Pharmacology, 1999
- Plasma mevalonate concentrations in uremic patientsKidney International, 1997
- Post-transcriptional regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase and cholesterol 7α-hydroxylase in rats with subtotal nephrectomyKidney International, 1994
- Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extractionAnalytical Biochemistry, 1987
- Diurnal rhythm of rat liver mRNAs encoding 3-hydroxy-3-methylglutaryl coenzyme A reductase. Correlation of functional and total mRNA levels with enzyme activity and protein.Journal of Biological Chemistry, 1984
- The effect of uremia on circulating mevalonate metabolism in ratsMetabolism, 1983
- Metabolism of plasma mevalonate in rats and humans.Journal of Lipid Research, 1982
- Micro assay for 3-hdyroxy-3-methylglutaryl-CoA reductase in rat liver and in L-cell fibroblastsBiochimica et Biophysica Acta (BBA) - Enzymology, 1974